On consolidated basis
Quarter ended December 2025 compared with Quarter ended December 2024.
Net sales (including other operating income) of Divis Laboratories has increased 12.29% to Rs 2604 crore. Operating profit margin has jumped from 32.04% to 34.18%, leading to 19.78% rise in operating profit to Rs 890.00 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 42.22% to 42.32%. Employee cost increased from 12.28% to 12.76%. Other expenses fell from 14.76% to 13.98%. Other income rose 7.32% to Rs 88 crore. PBIDT rose 18.55% to Rs 978 crore. Provision for interest remained nil. PBDT rose 17.82% to Rs 972 crore. Provision for depreciation rose 19.19% to Rs 118 crore. Profit before tax grew 17.63% to Rs 854.00 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 197 crore, compared to Rs 137 crore. Effective tax rate was 25.26% compared to 18.87%. Minority interest was nil in both the periods. Net profit attributable to owners of the company decreased 1.02% to Rs 583.00 crore. Promoters’ stake was 51.88% as of 31 December 2025 ,compared to 51.89% as of 31 December 2024 .
For year-to-date (YTD) results analysis.
Net sales (including other operating income) of Divis Laboratories has increased 14.08% to Rs 7729 crore. Operating profit margin has jumped from 30.73% to 32.44%, leading to 20.41% rise in operating profit to Rs 2,507.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 41.76% to 39.95%. Employee cost increased from 12.90% to 13.40%. Other expenses fell from 15.26% to 14.99%. Other income rose 32.33% to Rs 352 crore. PBIDT rose 21.76% to Rs 2859 crore. Provision for interest rose 1,600% to Rs 17 crore. PBDT rose 21.09% to Rs 2842 crore. Provision for depreciation rose 16.27% to Rs 343 crore. Profit before tax grew 21.78% to Rs 2,499.00 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 608 crore, compared to Rs 523 crore. Effective tax rate was 25.07% compared to 25.49%.Minority interest was nil in both the periods. Net profit attributable to owners of the company increased 18.84% to Rs 1,817.00 crore. Promoters’ stake was 51.88% as of 31 December 2025 ,compared to 51.89% as of 31 December 2024 .
Full year results analysis.
Net sales (including other operating income) of Divis Laboratories has increased 19.31% to Rs 9360 crore. Operating profit margin has jumped from 28.11% to 31.71%, leading to 34.60% rise in operating profit to Rs 2,968.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 40.63% to 40.41%. Employee cost decreased from 13.75% to 13.15%. Other expenses fell from 17.81% to 15.06%. Other income rose 3.83% to Rs 352 crore. PBIDT rose 30.50% to Rs 3320 crore. Provision for interest fell 33.33% to Rs 2 crore. Loan funds rose to Rs 4.00 crore as of 31 March 2025 from Rs 3.00 crore as of 31 March 2024. Inventories rose to Rs 3,236.00 crore as of 31 March 2025 from Rs 3,184.00 crore as of 31 March 2024. Sundry debtors were higher at Rs 2,731.00 crore as of 31 March 2025 compared to Rs 2,156.00 crore as of 31 March 2024. Cash and bank balance declined from Rs 3,980.00 crore as of 31 March 2024 to Rs 3,715.00 crore as of 31 March 2025. Investments declined from Rs 82.00 crore as of 31 March 2024 to Rs 65.00 crore as of 31 March 2025. PBDT rose 30.58% to Rs 3318 crore. Provision for depreciation rose 6.35% to Rs 402 crore. Fixed assets increased to Rs 6,460.00 crore as of 31 March 2025 from Rs 5,513.00 crore as of 31 March 2024. Intangible assets stood at Rs 4.00 crore. Profit before tax grew 34.81% to Rs 2,916.00 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 725 crore, compared to Rs 563 crore. Effective tax rate was 24.86% compared to 26.03%. Minority interest was nil in both the periods. Net profit attributable to owners of the company increased 36.94% to Rs 2,191.00 crore. Equity capital stood at Rs 53.00 crore as of 31 March 2025 to Rs 53.00 crore as of 31 March 2024. Per share face Value remained same at Rs 2.00. Promoters’ stake was 51.89% as of 31 March 2025 ,compared to 51.92% as of 31 March 2024 . Cash flow from operating activities increased to Rs 1,653.00 crore for year ended March 2025 from Rs 1,261.00 crore for year ended March 2024. Cash flow used in acquiring fixed assets during the year ended March 2025 stood at Rs 1,438.00 crore, compared to Rs 1,003.00 crore during the year ended March 2024. Other highlights
In Q3 FY26, Forex gain amounted to Rs 18
crore as against gain of Rs 11 crore in Q3 FY25.
| Divis Laboratories : Consolidated Results | | | Quarter ended | Year to Date | Year ended |
|---|
| Particulars | 202512 | 202412 | Var.(%) | 202512 | 202412 | Var.(%) | 202503 | 202403 | Var.(%) |
|---|
| Net Sales (including other operating income) | 2,604.00 | 2,319.00 | 12.29 | 7,729.00 | 6,775.00 | 14.08 | 9,360.00 | 7,845.00 | 19.31 | | OPM (%) | 34.18 | 32.04 | 214 bps | 32.44 | 30.73 | 171 bps | 31.71 | 28.11 | 360 bps | | OP | 890.00 | 743.00 | 19.78 | 2,507.00 | 2,082.00 | 20.41 | 2,968.00 | 2,205.00 | 34.60 | | Other Inc. | 88.00 | 82.00 | 7.32 | 352.00 | 266.00 | 32.33 | 352.00 | 339.00 | 3.83 | | PBIDT | 978.00 | 825.00 | 18.55 | 2,859.00 | 2,348.00 | 21.76 | 3,320.00 | 2,544.00 | 30.50 | | Interest | 6.00 | 0 | - | 17.00 | 1.00 | 1,600.00 | 2.00 | 3.00 | -33.33 | | PBDT | 972.00 | 825.00 | 17.82 | 2,842.00 | 2,347.00 | 21.09 | 3,318.00 | 2,541.00 | 30.58 | | Depreciation | 118 | 99 | 19.19 | 343 | 295 | 16.27 | 402 | 378 | 6.35 | | PBT | 854.00 | 726.00 | 17.63 | 2499 | 2052 | 21.78 | 2916 | 2163 | 34.81 | | Share of Profit/(Loss) from Associates | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | PBT before EO | 854 | 726 | 17.63 | 2499 | 2052 | 21.78 | 2916 | 2163 | 34.81 | | EO Income | -74 | 0 | - | -74 | 0 | - | 0 | 0 | - | | PBT after EO | 780 | 726 | 7.44 | 2425 | 2052 | 18.18 | 2916 | 2163 | 34.81 | | Taxation | 197 | 137 | 43.80 | 608 | 523 | 16.25 | 725 | 563 | 28.77 | | PAT | 583 | 589 | -1.02 | 1817 | 1529 | 18.84 | 2191 | 1600 | 36.94 | | Minority Interest (MI) | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit | 583 | 589 | -1.02 | 1817 | 1529 | 18.84 | 2191 | 1600 | 36.94 | | P/(L) from discontinued operations net of tax | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit after discontinued operations | 583 | 589 | -1.02 | 1817 | 1529 | 18.84 | 2191 | 1600 | 36.94 | | EPS (Rs)* | 24.04 | 22.19 | 8.37 | 70.53 | 57.60 | 22.46 | 82.53 | 60.27 | 36.94 | | | * EPS is on current equity of Rs 53.09 crore, Face value of Rs 2, Excluding extraordinary items. | | # EPS is not annualised | | bps : Basis points | | EO : Extraordinary items | | Figures in Rs crore | | Source: Capitaline Corporate Database |
|
|